journal article·2018-02

A nephron model for study of drug-induced acute kidney injury and assessment of drug-induced nephrotoxicity

Yueyang Qu, Fan An, Yong Luo, Yao Lu, Tingjiao Liu, Weijie Zhao, Bingcheng Lin

Biomaterials· Volume 155
Publisher page

Abstract

In this study, we developed a multilayer microfluidic device to simulate nephron, which was formed by "glomerulus", "Bowman's capsule", "proximal tubular lumen" and "peritubular capillary". In this microdevice, artificial renal blood flow was circulating and glomerular filtrate flow was single passing through, mimicking the behavior of a nephron. In this dynamic artificial nephron, we observed typical renal physiology, including the glomerular size-selective barrier, glomerular basement membrane charge-selective barrier, glucose reabsorption and para-aminohippuric acid secretion. To demonstrate the capability of our microdevice, we used it to investigate the pathophysiology of drug-induced acute kidney injury (AKI) and give assessment of drug-induced nephrotoxicity, with cisplatin and doxorubicin as model drugs. In the experiment, we loaded the doxorubicin or cisplatin in the "renal blood flow", recorded the injury of primary glomerular endothelial cells, podocytes, tubular epithelial cells and peritubular endothelial cells by fluorescence imaging, and identified the time-dependence, dose-dependence and the death order of four types of renal cells. Then by measuring multiple biomarkers, including E-cadherin, VEGF, VCAM-1, Nephrin, and ZO-1, we studied the mechanism of cell injuries caused by doxorubicin or cisplatin. Also, we investigated the effect of BSA in the "renal blood flow" on doxorubicin-or-cisplatin-induced nephrotoxicity, and found that BSA enhanced the tight junctions between cells and eased cisplatin-induced nephrotoxicity. In addition, we compared the nephron model and traditional tubule models for assessment of drug-induced nephrotoxicity. And it can be inferred that our biomimetic microdevice simulated the complex, dynamic microenvironment of nephron, yielded abundant information about drug-induced-AKI at the preclinical stage, boosted the drug safety evaluation, and provided a reliable reference for clinical therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Chemotherapy-induced organ toxicity mitigation · Acute Kidney Injury Research · Lanthanide and Transition Metal Complexes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (33)

Show source-provided references
1. Acute kidney injury
2. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup10.1038/nrneph.2017.2 ↗
3. An overview of drug-induced acute kidney injury10.1097/CCM.0b013e318168e375 ↗
4. Acute kidney injury10.1016/S0140-6736(12)62105-9 ↗
5. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients10.1681/ASN.2004090740 ↗
6. Acute renal failure and sepsis
7. Acute kidney injury: alkaline phosphatase in sepsis-induced AKI10.1038/nrneph.2012.1 ↗
8. F.,Reno-Cerebral reflex activates the renin-angiotensin system, promoting oxidative stress and renal damage after ischemia-reperfusion injury10.1089/ars.2016.6827 ↗
9. Quantified kidney echogenicity in mice with renal ischemia reperfusion injury: evaluation as a noninvasive biomarker of acute kidney injury10.1007/s00795-017-0157-8 ↗
10. The novel nitric oxide donor PDNO attenuates ovine ischemia-reperfusion induced renal failure10.1186/s40635-017-0143-4 ↗
11. Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity10.1016/j.taap.2009.11.019 ↗
12. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies10.1038/sj.ki.5002786 ↗
13. A metabolic profiling analysis of the acute hepatotoxicity and nephrotoxicity of Zhusha Anshen Wan compared with cinnabar in rats using H-1 NMR spectroscopy10.1016/j.jep.2013.01.026 ↗
14. Drug-induced nephrotoxicity
15. Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models10.1021/mp400720w ↗
16. Discovery of metabolomics biomarkers for early detection of nephrotoxicity10.1177/0192623309332992 ↗
17. Treatment-related acute renal failure in the elderly: a hospital-based prospective study10.1093/ndt/15.2.212 ↗
18. Kidney-on-a-Chip technology for drug-incuced nephrotoxiciy screening10.1016/j.tibtech.2015.11.001 ↗
19. Albumin handling by renal tubular epithelial cells in a microfluidic bioreactor10.1002/bit.24339 ↗
20. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment10.1039/c3ib40049b ↗
21. A disease model of diabetic nephropathy in a glomerulus-on-a-chip microdevice10.1039/C7LC00134G ↗
22. Engineering a 3D vascular network in hydrogel for mimicking a nephron10.1039/c3lc41342j ↗
23. Biomarkers of nephrotoxic acute kidney injury10.1016/j.tox.2007.12.024 ↗
24. Biomarkers of acute kidney injury10.1146/annurev.pharmtox.48.113006.094615 ↗
25. Adriamycin nephrotoxicity
26. Adriamycin and adriamycin-DNA nephrotoxicity in rats
27. Cisplatin nephrotoxicity
28. Fauvelle · 1992 · 408
29. Pharmacokinetics of quinidine in man as influenced by its plasma-protein binding
30. Soft lithography in biology and biochemistry10.1146/annurev.bioeng.3.1.335 ↗
31. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines10.1006/excr.1997.3739 ↗
32. Isolation, culture, and characterization of endothelial cells from mouse glomeruli10.1111/j.1523-1755.2004.00634.x ↗
33. Isolation and epithelial co-culture of mouse renal peritubular endothelial cells10.1186/s12860-014-0040-6 ↗